Logo image of AGS.BR

AGEAS (AGS.BR) Stock Fundamental Analysis

Europe - EBR:AGS - BE0974264930 - Common Stock

58 EUR
-0.4 (-0.68%)
Last: 10/3/2025, 7:00:00 PM
Fundamental Rating

4

Taking everything into account, AGS scores 4 out of 10 in our fundamental rating. AGS was compared to 40 industry peers in the Insurance industry. AGS has a medium profitability rating, but doesn't score so well on its financial health evaluation. AGS is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

AGS had positive earnings in the past year.
AGS had a positive operating cash flow in the past year.
Each year in the past 5 years AGS has been profitable.
The reported operating cash flow has been mixed in the past 5 years: AGS reported negative operating cash flow in multiple years.
AGS.BR Yearly Net Income VS EBIT VS OCF VS FCFAGS.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B

1.2 Ratios

AGS's Return On Assets of 1.16% is in line compared to the rest of the industry. AGS outperforms 47.50% of its industry peers.
Looking at the Return On Equity, with a value of 14.28%, AGS is in line with its industry, outperforming 52.50% of the companies in the same industry.
Industry RankSector Rank
ROA 1.16%
ROE 14.28%
ROIC N/A
ROA(3y)1.08%
ROA(5y)1.01%
ROE(3y)14.33%
ROE(5y)11.99%
ROIC(3y)N/A
ROIC(5y)N/A
AGS.BR Yearly ROA, ROE, ROICAGS.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

AGS has a better Profit Margin (12.73%) than 80.00% of its industry peers.
AGS's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 14.60%, AGS is in the better half of the industry, outperforming 72.50% of the companies in the same industry.
AGS's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 14.6%
PM (TTM) 12.73%
GM N/A
OM growth 3Y20.52%
OM growth 5Y15.89%
PM growth 3Y24.5%
PM growth 5Y12.46%
GM growth 3YN/A
GM growth 5YN/A
AGS.BR Yearly Profit, Operating, Gross MarginsAGS.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

2

2. Health

2.1 Basic Checks

AGS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AGS has less shares outstanding
AGS has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, AGS has a worse debt to assets ratio.
AGS.BR Yearly Shares OutstandingAGS.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
AGS.BR Yearly Total Debt VS Total AssetsAGS.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

The Debt to FCF ratio of AGS is 3.64, which is a good value as it means it would take AGS, 3.64 years of fcf income to pay off all of its debts.
AGS has a Debt to FCF ratio of 3.64. This is comparable to the rest of the industry: AGS outperforms 50.00% of its industry peers.
A Debt/Equity ratio of 0.65 indicates that AGS is somewhat dependend on debt financing.
AGS's Debt to Equity ratio of 0.65 is in line compared to the rest of the industry. AGS outperforms 47.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 3.64
Altman-Z N/A
ROIC/WACCN/A
WACC7.11%
AGS.BR Yearly LT Debt VS Equity VS FCFAGS.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
AGS.BR Yearly Current Assets VS Current LiabilitesAGS.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

4

3. Growth

3.1 Past

AGS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.02%, which is quite good.
The Earnings Per Share has been growing slightly by 3.68% on average over the past years.
Looking at the last year, AGS shows a small growth in Revenue. The Revenue has grown by 7.62% in the last year.
AGS shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -8.69% yearly.
EPS 1Y (TTM)8.02%
EPS 3Y10.44%
EPS 5Y3.68%
EPS Q2Q%4.61%
Revenue 1Y (TTM)7.62%
Revenue growth 3Y-11.82%
Revenue growth 5Y-8.69%
Sales Q2Q%3.31%

3.2 Future

The Earnings Per Share is expected to grow by 4.32% on average over the next years.
Based on estimates for the next years, AGS will show a quite strong growth in Revenue. The Revenue will grow by 9.56% on average per year.
EPS Next Y5.32%
EPS Next 2Y5.86%
EPS Next 3Y6.86%
EPS Next 5Y4.32%
Revenue Next Year9.98%
Revenue Next 2Y6.79%
Revenue Next 3Y6.01%
Revenue Next 5Y9.56%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
AGS.BR Yearly Revenue VS EstimatesAGS.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B
AGS.BR Yearly EPS VS EstimatesAGS.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 9.28 indicates a reasonable valuation of AGS.
Compared to the rest of the industry, the Price/Earnings ratio of AGS indicates a rather cheap valuation: AGS is cheaper than 97.50% of the companies listed in the same industry.
AGS is valuated cheaply when we compare the Price/Earnings ratio to 27.86, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 7.63, which indicates a rather cheap valuation of AGS.
87.50% of the companies in the same industry are more expensive than AGS, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of AGS to the average of the S&P500 Index (23.32), we can say AGS is valued rather cheaply.
Industry RankSector Rank
PE 9.28
Fwd PE 7.63
AGS.BR Price Earnings VS Forward Price EarningsAGS.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AGS is valued a bit cheaper than the industry average as 75.00% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, AGS is valued a bit cheaper than the industry average as 67.50% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 8
EV/EBITDA 8.07
AGS.BR Per share dataAGS.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.74
PEG (5Y)2.53
EPS Next 2Y5.86%
EPS Next 3Y6.86%

6

5. Dividend

5.1 Amount

AGS has a Yearly Dividend Yield of 4.20%, which is a nice return.
Compared to an average industry Dividend Yield of 4.62, AGS has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.41, AGS pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.2%

5.2 History

The dividend of AGS is nicely growing with an annual growth rate of 8.13%!
Dividend Growth(5Y)8.13%
Div Incr Years1
Div Non Decr Years1
AGS.BR Yearly Dividends per shareAGS.BR Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3 4 5

5.3 Sustainability

54.29% of the earnings are spent on dividend by AGS. This is a bit on the high side, but may be sustainable.
The dividend of AGS is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP54.29%
EPS Next 2Y5.86%
EPS Next 3Y6.86%
AGS.BR Yearly Income VS Free CF VS DividendAGS.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B -1.5B
AGS.BR Dividend Payout.AGS.BR Dividend Payout, showing the Payout Ratio.AGS.BR Dividend Payout.PayoutRetained Earnings

AGEAS

EBR:AGS (10/3/2025, 7:00:00 PM)

58

-0.4 (-0.68%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)08-27 2025-08-27
Earnings (Next)02-10 2026-02-10/amc
Inst Owners39.79%
Inst Owner ChangeN/A
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap11.54B
Analysts76
Price Target61.35 (5.78%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.2%
Yearly Dividend3.19
Dividend Growth(5Y)8.13%
DP54.29%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)8.29%
PT rev (3m)8.61%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.68%
EPS NY rev (3m)-1.07%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.23%
Revenue NY rev (3m)0.78%
Valuation
Industry RankSector Rank
PE 9.28
Fwd PE 7.63
P/S 1.27
P/FCF 8
P/OCF 6.32
P/B 1.43
P/tB 1.8
EV/EBITDA 8.07
EPS(TTM)6.25
EY10.78%
EPS(NY)7.6
Fwd EY13.11%
FCF(TTM)7.25
FCFY12.5%
OCF(TTM)9.18
OCFY15.83%
SpS45.51
BVpS40.6
TBVpS32.18
PEG (NY)1.74
PEG (5Y)2.53
Profitability
Industry RankSector Rank
ROA 1.16%
ROE 14.28%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 14.6%
PM (TTM) 12.73%
GM N/A
FCFM 15.93%
ROA(3y)1.08%
ROA(5y)1.01%
ROE(3y)14.33%
ROE(5y)11.99%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)1.35%
ROCE(5y)1.3%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y20.52%
OM growth 5Y15.89%
PM growth 3Y24.5%
PM growth 5Y12.46%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 3.64
Debt/EBITDA 3.18
Cap/Depr 117.74%
Cap/Sales 4.25%
Interest Coverage 4.77
Cash Conversion 110.79%
Profit Quality 125.07%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score7
WACC7.11%
ROIC/WACCN/A
Cap/Depr(3y)80.34%
Cap/Depr(5y)60.12%
Cap/Sales(3y)3.25%
Cap/Sales(5y)2.79%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)8.02%
EPS 3Y10.44%
EPS 5Y3.68%
EPS Q2Q%4.61%
EPS Next Y5.32%
EPS Next 2Y5.86%
EPS Next 3Y6.86%
EPS Next 5Y4.32%
Revenue 1Y (TTM)7.62%
Revenue growth 3Y-11.82%
Revenue growth 5Y-8.69%
Sales Q2Q%3.31%
Revenue Next Year9.98%
Revenue Next 2Y6.79%
Revenue Next 3Y6.01%
Revenue Next 5Y9.56%
EBIT growth 1Y0.61%
EBIT growth 3Y6.27%
EBIT growth 5Y5.82%
EBIT Next Year-22.77%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y288.68%
FCF growth 3YN/A
FCF growth 5Y18.15%
OCF growth 1Y222.22%
OCF growth 3YN/A
OCF growth 5Y17.48%